Matrix metalloproteinases and tumor metastasis
The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H., Sioka, C., & Rao, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408520200 · Cited by 136
RetractedLakka, S. S., Rajan, M., Gondi, C. S., Yanamandra, N., Chandrasekar, N., Jasti, S. L., Adachi, Y., Siddique, K., Gujrati, M., Olivero, W. C., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205894 · Cited by 92
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 2×
“Gene profiling indicated that subsequent selection of human breast carcinoma cell lines, metastatic to lung in a xenograft model, resulted in overexpression of MMP-1 and MMP-2 genes compared with the original parental MDA-MB-231 cell line [51].”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980) · Nature · doi:10.1038/284067a0 · Cited by 1,768
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,751
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Self-citationTumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.
Liotta, L. A. (1986) · PubMed · Cited by 1,400
Compensation mechanism in tumor cell migration
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Bröcker, E.-B., & Friedl, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209006 · Cited by 1,391
Self-citationStrategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Dissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
Multistep Nature of Metastatic Inefficiency
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., & Groom, A. C. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65628-3 · Cited by 1,243
Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., & Condeelis, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1449 · Cited by 1,188
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
Regulation of matrix biology by matrix metalloproteinases
Mott, J. D., & Werb, Z. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.07.010 · Cited by 1,104
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 1×
“The recent successful use of MMP inhibitors in animal models clearly indicated that the most effective target for treatment was the early stages of cancer associated with tumor-induced angiogenesis [109].”
BackgroundMatrix metalloproteinases and angiogenesis
Rundhaug, J. E. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00355.x · Cited by 960
Intravital imaging of cell movement in tumours
Condeelis, J., & Segall, J. E. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1231 · Cited by 929
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., & Werb, Z. (1999) · Cell · doi:10.1016/s0092-8674(00)81009-0 · Cited by 924
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
Matrix metalloproteinases in tumor invasion and metastasis
Stamenkovic, I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0379 · Cited by 815
(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60034-2 · Cited by 800
Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Pepper, M. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.093685 · Cited by 777
Goswami, S., Sahai, E., Wyckoff, J. B., Cammer, M., Cox, D., Pixley, F. J., Stanley, E. R., Segall, J. E., & Condeelis, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1853 · Cited by 738
In vivo molecular target assessment of matrix metalloproteinase inhibition
Bremer, C., Tung, C.-H., & Weissleder, R. (2001) · Nature Medicine · doi:10.1038/89126 · Cited by 726
Al-Mehdi, A. B., Tozawa, K., Fisher, A. B., Shientag, L., Lee, A., & Muschel, R. J. (2000) · Nature Medicine · doi:10.1038/71429 · Cited by 706
Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D., & Iruela-Arispe, M. L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409115 · Cited by 703
Giraudo, E., Inoue, M., & Hanahan, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422087 · Cited by 700
Voura, E. B., Jaiswal, J. K., Mattoussi, H., & Simon, S. M. (2004) · Nature Medicine · doi:10.1038/nm1096 · Cited by 688
Hotary, K. B., Allen, E. D., Brooks, P. C., Datta, N. S., Long, M. W., & Weiss, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00513-0 · Cited by 676
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. M., & Matrisian, L. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1402 · Cited by 609
Foot and mouth: podosomes, invadopodia and circular dorsal ruffles
Buccione, R., Orth, J. D., & McNiven, M. A. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1436 · Cited by 594
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
Folgueras, A. R., Pendas, A. M., Sanchez, L. M., & Lopez-Otin, C. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041811af · Cited by 590
Sabeh, F., Ota, I., Holmbeck, K., Birkedal-Hansen, H., Soloway, P., Balbin, M., Lopez-Otin, C., Shapiro, S., Inada, M., Krane, S., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408028 · Cited by 586
Therapeutic targeting of the tumor microenvironment
Joyce, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.024 · Cited by 582
The significance of hematogenous tumor cell clumps in the metastatic process.
Liotta, L. A., Saidel, M. G., & Kleinerman, J. I. (1976) · PubMed · Cited by 567
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 559
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
Balbín, M., Fueyo, A., Tester, A. M., Pendás, A. M., Pitiot, A. S., Astudillo, A., Overall, C. M., Shapiro, S. D., & López-Otín, C. (2003) · Nature Genetics · doi:10.1038/ng1249 · Cited by 536
The role of gelatinases in colorectal cancer progression and metastasis
Mook, O. R. F., Frederiks, W. M., & Van Noorden, C. J. F. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.006 · Cited by 511
Role of matrix metalloproteinases (MMPs) in colorectal cancer
Zucker, S., & Vacirca, J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025867130437 · Cited by 506
MT1‐MMP: A potent modifier of pericellular microenvironment
Itoh, Y., & Seiki, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20431 · Cited by 499
Weis, S., Cui, J., Barnes, L., & Cheresh, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408130 · Cited by 477
Yu, W.-H., Woessner, J. F., McNeish, J. D., & Stamenkovic, I. (2002) · Genes & Development · doi:10.1101/gad.925702 · Cited by 471
Kim, J., Yu, W., Kovalski, K., & Ossowski, L. (1998) · Cell · doi:10.1016/s0092-8674(00)81478-6 · Cited by 468
Khanna, C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh261 · Cited by 463
Activity-based probes for the proteomic profiling of metalloproteases
Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M., & Cravatt, B. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402784101 · Cited by 456
Matrix Metalloproteinases Generate Angiostatin: Effects on Neovascularization
Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A., & Shapiro, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6845 · Cited by 444
Ii, M., Yamamoto, H., Adachi, Y., Maruyama, Y., & Shinomura, Y. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100103 · Cited by 443
Mitsiades, N., Yu, W., Poulaki, V., Tsokos, M., & Stamenkovic, I. (2001) · PubMed · Cited by 441
Nakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y., & Chen, W.-T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7959 · Cited by 425
(2000) · PubMed · Cited by 404
Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P., & Gardner, H. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040378497 · Cited by 395
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
Fang, J., Shing, Y., Wiederschain, D., Yan, L., Butterfield, C., Jackson, G., Harper, J., Tamvakopoulos, G., & Moses, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3884 · Cited by 393
THE GREAT ESCAPE: When Cancer Cells Hijack the Genes for Chemotaxis and Motility
Condeelis, J., Singer, R. H., & Segall, J. E. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120306 · Cited by 391
Matrix metalloproteinases in tumor–host cell communication
Lynch, C. C., & Matrisian, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700909.x · Cited by 386
Generation and degradation of human endostatin proteins by various proteinases
Ferreras, M., Felbor, U., Lenhard, T., Olsen, B. R., & Delaissé, J.-M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02249-3 · Cited by 377
Nash, G., Turner, L., Scully, M., & Kakkar, A. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00789-1 · Cited by 366
Jurasz, P., Alonso‐Escolano, D., & Radomski, M. W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706013 · Cited by 357
Huang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349
Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer
Kerkelä, E., & Saarialho‐Kere, U. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.120201.x · Cited by 345
The paradox of matrix metalloproteinases in infectious disease
Elkington, P. T. G., O'Kane, C. M., & Friedland, J. S. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02840.x · Cited by 340
Ala-aho, R., & Kähäri, V.-M. (2005) · Biochimie · doi:10.1016/j.biochi.2004.12.009 · Cited by 325
Experimental metastasis is suppressed in MMP-9-deficient mice
Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., & Uehira, M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006603723759 · Cited by 308
Metalloproteinases and their inhibitors in tumor angiogenesis
Handsley, M. M., & Edwards, D. R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20945 · Cited by 307
Mori, H., Tomari, T., Koshikawa, N., Kajita, M., Itoh, Y., Sato, H., Tojo, H., Yana, I., & Seiki, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf411 · Cited by 296
Masson, R., Lefebvre, O., Noël, A., Fahime, M. E., Chenard, M.-P., Wendling, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J.-M., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1535 · Cited by 291
Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
Turpeenniemi-Hujanen, T. (2005) · Biochimie · doi:10.1016/j.biochi.2005.01.014 · Cited by 289
Role of Inflammatory Mediators in Angiogenesis
Naldini, A., & Carraro, F. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010053622830 · Cited by 287
Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schäfer, R., Stanley, E. R., & Abraham, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0961 · Cited by 281
Kallakury, B., Karikehalli, S., Haholu, A., Sheehan, C. E., Azumi, N., & Ross, J. S. (2001) · PubMed · Cited by 280
Role of infiltrated leucocytes in tumour growth and spread
Lin, E. Y., & Pollard, J. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601705 · Cited by 278
Matrix Metalloproteinases as Therapeutic Targets in Cancer
Vihinen, P., Ala-aho, R., & Kahari, V.-M. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765799 · Cited by 277
Matrix metalloproteinases: roles in cancer and metastasis
Fingleton, B. (2006) · Frontiers in Bioscience · doi:10.2741/1811 · Cited by 271
Bourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu, B., Hsu, S.-M., Ho, H., Lien, H., Huang, S., & Lin, R. H. (2001) · PubMed · Cited by 268
Molecular prognostic markers in pancreatic cancer: A systematic review
Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.044 · Cited by 259
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
Sternlicht, M. D., Bissell, M. J., & Werb, Z. (2000) · Oncogene · doi:10.1038/sj.onc.1203347 · Cited by 256
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development
Hojilla, C. V., Mohammed, F. F., & Khokha, R. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601327 · Cited by 246
Zijlstra, A., Mellor, R. L., Panzarella, G., Aimes, R. T., Hooper, J. D., Marchenko, N. D., & Quigley, J. P. (2002) · PubMed · Cited by 244
Self-citationBreast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β
Stuelten, C. H., Byfield, S. D., Arany, P. R., Karpova, T. S., Stetler-Stevenson, W. G., & Roberts, A. B. (2005) · Journal of Cell Science · doi:10.1242/jcs.02334 · Cited by 238
The tumor microenvironment: a critical determinant of neoplastic evolution
van Kempen, L. C. L. T., Ruiter, D. J., van Muijen, G. N. P., & Coussens, L. M. (2003) · European Journal of Cell Biology · doi:10.1078/0171-9335-00346 · Cited by 231
Crawford, H. C., Scoggins, C. R., Washington, M. K., Matrisian, L. M., & Leach, S. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215051 · Cited by 226
Rao, B. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382115 · Cited by 221
Chantrain, C. F., Shimada, H., Jodele, S., Groshen, S., Ye, W., Shalinsky, D. R., Werb, Z., Coussens, L. M., & DeClerck, Y. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0160 · Cited by 218
Heljasvaara, R., Nyberg, P., Luostarinen, J., Parikka, M., Heikkilä, P., Rehn, M., Sorsa, T., Salo, T., & Pihlajaniemi, T. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.021 · Cited by 217
Hua, J., & Muschel, R. J. (1996) · PubMed · Cited by 211
Expression of MMP2, MMP9 and MMP3 in Breast Cancer Brain Metastasis in a Rat Model
Mendes, O., Kim, H.-T., & Stoica, G. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-8115-6 · Cited by 210
Acuff, H. B., Carter, K. J., Fingleton, B., Gorden, D. L., & Matrisian, L. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2502 · Cited by 200
Nikkola, J., Vihinen, P., Vuoristo, M.-S., Kellokumpu-Lehtinen, P., Kähäri, V.-M., & Pyrhönen, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2478 · Cited by 199
Lymphangiogenesis and tumor metastasis
Pepper, M. S., Tille, J.-C., Nisato, R., & Skobe, M. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0748-7 · Cited by 198
Keck, T., Balcom, J. H., Castillo, C. F., Antoniu, B. A., & Warshaw, A. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.30348 · Cited by 189
Xue, C., Wyckoff, J., Liang, F., Sidani, M., Violini, S., Tsai, K.-L., Zhang, Z.-Y., Sahai, E., Condeelis, J., & Segall, J. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1242 · Cited by 188
Role of matrix metalloproteinases in melanoma cell invasion
Hofmann, U. B., Houben, R., Bröcker, E.-B., & Becker, J. C. (2005) · Biochimie · doi:10.1016/j.biochi.2005.01.013 · Cited by 176
Cell surface association of matrix metalloproteinase-9 (gelatinase B)
Fridman, R. A., Tóth, M., Chvyrkova, I., Meroueh, S. O., & Mobashery, S. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023091214123 · Cited by 174
Regulation of membrane type-matrix metalloproteinases
Hernandez-Barrantes, S., Bernardo, M., Toth, M., & Fridman, R. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0421 · Cited by 174
Hynes, R. O. (2003) · Cell · doi:10.1016/s0092-8674(03)00468-9 · Cited by 173
Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells
Aalinkeel, R., Nair, M., Sufrin, G., Mahajan, S. D., Chadha, K. C., Chawda, R. P., & Schwartz, S. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2506-2 · Cited by 173
Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.
Koop, S., MacDonald, I. C., Luzzi, K. J., Schmidt, E. E., Morris, V. L., Grattan, M., Khokha, R., Chambers, A. F., & Groom, A. C. (1995) · PubMed · Cited by 173
Montel, V., Kleeman, J., Agarwal, D., Spinella, D., Kawai, K., & Tarin, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2047 · Cited by 169
Mira, E., Lacalle, R. A., Buesa, J. M., de Buitrago, G. G., Jiménez-Baranda, S., Gómez‐Moutón, C., Martínez‐A, C., & Mañes, S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01035 · Cited by 167
Montgomery, A. M. P., Mueller, B. M., Reisfeld, R., Taylor, S. M., & DeClerck, Y. A. (1994) · PubMed · Cited by 166
Nyberg, P., Heikkilä, P., Sorsa, T., Luostarinen, J., Heljasvaara, R., Stenman, U.-H., Pihlajaniemi, T., & Salo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210325200 · Cited by 166
Yamauchi, K., Yang, M., Jiang, P., Yamamoto, N., Xu, M., Amoh, Y., Tsuji, K., Bouvet, M., Tsuchiya, H., Tomita, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0069 · Cited by 162
CHEN, W., & WANG, J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07695.x · Cited by 161
A Protective Role for Matrix Metalloproteinase-3 in Squamous Cell Carcinoma
McCawley, L. J., Crawford, H. C., King, L. E., Mudgett, J. S., & Matrisian, L. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0910 · Cited by 161
Kondraganti, S. R., Mohanam, S., Chintala, S. K., Kin, Y., Jasti, S. L., Nirmala, C., Lakka, S. S., Adachi, Y., Kyritsis, A. P., Ali‐Osman, F., et al. (2000) · PubMed · Cited by 160
Jodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., Coussens, L. M., & DeClerck, Y. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3770 · Cited by 159
Membrane type-matrix metalloproteinases and tumor progression
Sounni, N. E., & Noël, A. (2004) · Biochimie · doi:10.1016/j.biochi.2004.07.012 · Cited by 158
Deryugina, E. I., Soroceanu, L., & Strongin, A. Y. (2002) · PubMed · Cited by 158
Self-citationLow plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
Pozzi, A., LeVine, W. F., & Gardner, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205045 · Cited by 154
Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics
Mannello, F., Tonti, G., & Papa, S. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009054064615 · Cited by 151
Rao, J. S., Gondi, C., Chetty, C., Chittivelu, S., Joseph, P. A., & Lakka, S. S. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0082 · Cited by 151
Physiological Mechanisms of Tumor-Cell Invasion and Migration
Geho, D. H., Bandle, R., Clair, T., & Liotta, L. A. (2005) · Physiology · doi:10.1152/physiol.00009.2005 · Cited by 147
Matrix metalloproteinases in colorectal cancer: Is it worth talking about?
Wagenaar-Miller, R. A., Gorden, L. D., & Matrisian, L. M. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1025819214508 · Cited by 146
Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases
Chantrain, C. F., Henriet, P., Jodele, S., Emonard, H., Féron, O., Courtoy, P. J., DeClerck, Y. A., & Marbaix, É. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.010 · Cited by 144
D'Armiento, J., DiColandrea, T., Dalal, S. S., Okada, Y., Huang, M.-T., Conney, A. H., & Chada, K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5732 · Cited by 142
Coevolution of cancer and stromal cellular responses
Littlepage, L. E., Egeblad, M., & Werb, Z. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.019 · Cited by 138
Ha, H. Y., Moon, H. B., Nam, M. S., Lee, J., Ryoo, Z. Y., Lee, T., Lee, K. K., So, B. J., Sato, H., Seiki, M., et al. (2001) · PubMed · Cited by 137
Potent Mechanism-based Inhibitors for Matrix Metalloproteinases
Ikejiri, M., Bernardo, M. M., Bonfil, R. D., Tóth, M., Chang, M., Fridman, R. A., & Mobashery, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504303200 · Cited by 136
Human neutrophils facilitate tumor cell transendothelial migration
Wu, Q. D., Wang, J. H., Condron, C., Bouchier-Hayes, D., & Redmond, H. P. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c814 · Cited by 135
Diminished corneal angiogenesis in gelatinase A‐deficient mice
Kato, T., Kure, T., Chang, J.-H., Gabison, E. E., Itoh, T., Itohara, S., & Azar, D. T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02897-6 · Cited by 134
Hamano, Y., & Kalluri, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.130 · Cited by 134
Allport, J. R., Lim, Y.-C., Shipley, J. M., Senior, R. M., Shapiro, S. D., Matsuyoshi, N., Vestweber, D., & Luscinskas, F. W. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.5.821 · Cited by 133
Agarwal, D., Steve Goodison, B., Nicholson, B., Tarin, D., & Urquidi, V. (2003) · Differentiation · doi:10.1046/j.1432-0436.2003.710202.x · Cited by 129
Alonso‐Escolano, D., Strongin, A. Y., Chung, A. W. Y., Deryugina, E. I., & Radomski, M. W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705606 · Cited by 129
Self-citationAntimetastatic Activity of a Novel Mechanism-Based Gelatinase Inhibitor
Krüger, A., Arlt, M., Gerg, M., Kopitz, C., Bernardo, M. M., Chang, M., Mobashery, S., & Fridman, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3570 · Cited by 127
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.
Krüger, A., Soeltl, R., Sopov, I., Kopitz, C., Arlt, M., Magdolen, V., Harbeck, N., Gänsbacher, B., & Schmitt, M. (2001) · PubMed · Cited by 127
Boulay, A., Masson, R., Chenard, M., Fahime, E. E., Cassard, L., Bellocq, J., Sautès‐Fridman, C., Basset, P., & Rio, M. C. (2001) · PubMed · Cited by 127
Sancéau, J., Truchet, S., & Bauvois, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304300200 · Cited by 123
Tsunezuka, Y., Kinoh, H., Takino, T., Watanabe, Y., Okada, Y., Shinagawa, A., Sato, H., & Seiki, M. (1996) · PubMed · Cited by 122
Matrix metalloproteinases and metastatic cancer.
Cockett, M. I., Murphy, G., Birch, M. L., Jp, O., Crabbe, T., At, M., Hart, I. R., & Aj, D. (1998) · PubMed · Cited by 120
The Significance of Matrix Metalloproteinases during Early Stages of Tumor Progressiona
Lochter, A., Sternlicht, M. D., Werb, Z., & Bissell, M. J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10116.x · Cited by 119
Hofmann, U. B., Eggert, A. A. O., Blass, K., Bröcker, E., & Becker, J. C. (2003) · PubMed · Cited by 113
Role of Tumor Cell Adhesion and Migration in Organ-Specific Metastasis Formation
Gaßmann, P., Enns, A., & Haier, J. (2004) · Oncology Research and Treatment · doi:10.1159/000081343 · Cited by 112
Reduced Choroidal Neovascular Membrane Formation in Matrix Metalloproteinase-2–Deficient Mice
Berglin, L., Sarman, S., van der Ploeg, I., Steén, B., Ming, Y., Itohara, S., Seregard, S., & Kvanta, A. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0180 · Cited by 109
Kupferman, M. E., Fini, M. E., Muller, W. J., Weber, R. S., Cheng, Y., & Muschel, R. J. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64815-8 · Cited by 108
Role of c-kit/Kit ligand signaling in regulating vasculogenesis
Heissig, B., Werb, Z., Rafii, S., & Hattori, K. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-03-0188 · Cited by 106
Nakajima, M., Welch, D. R., Wynn, D. M., Tsuruo, T., & Nicolson, G. L. (1993) · PubMed · Cited by 105
Visualization of Early Events in Tumor Formation of Egfp–Transfected Rat Colon Cancer Cells in Liver
Mook, O. R. F., van Marle, J., Vreeling‐Sindelárová, H., Jonges, R., Frederiks, W. M., & Noorden, C. J. F. V. (2003) · Hepatology · doi:10.1053/jhep.2003.50297 · Cited by 104
Collagenolysis-dependent Angiogenesis Mediated by Matrix Metalloproteinase-13 (Collagenase-3)
Zijlstra, A., Aimes, R. T., Zhu, D., Regazzoni, K., Kupriyanova, T. A., Seandel, M., Deryugina, E. I., & Quigley, J. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313617200 · Cited by 99
Self-citationZhai, Y., Hotary, K. B., Nan, B., Bosch, F. X., Muñoz, N., Weiss, S. J., & Cho, K. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0231 · Cited by 97
Mackarel, A. J., Cottell, D. C., Russell, K. J., FitzGerald, M. X., & O'CONNOR, C. M. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.6.3539 · Cited by 96
Bonfil, R. D., Sabbota, A. L., Nabha, S. M., Bernardo, M. M., Dong, Z., Hong, M., Yamamoto, H., Chinni, S. R., Lim, I. T., Chang, M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21645 · Cited by 95
London, C. A., Sekhon, H. S., Arora, V., Stein, D. A., Iversen, P. L., & Devi, G. R. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700642 · Cited by 95
Wylie, S., MacDonald, I. C., Varghese, H. J., Schmidt, E. E., Morris, V. L., Groom, A. C., & Chambers, A. F. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006573417179 · Cited by 94
Deryugina, E. I., Zijlstra, A., Partridge, J. J., Kupriyanova, T. A., Madsen, M. A., Papagiannakopoulos, T. Y., & Quigley, J. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2228 · Cited by 94
Self-citationIdentification of MMP-15 as an Anti-apoptotic Factor in Cancer Cells
Abraham, R., Schäfer, J., Rothe, M., Bange, J., Knyazev, P. G., & Ullrich, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508155200 · Cited by 92
Reduced Retinal Angiogenesis in MMP-2–Deficient Mice
Ohno‐Matsui, K., Uetama, T., Yoshida, T., Hayano, M., Itoh, T., Morita, I., & Mochizuki, M. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0249 · Cited by 90
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa, K. L., Boulay, A., Masson, R., Mathelin, C., Stoll, I., Tomasetto, C., Chenard, M., Gintz, M., Bellocq, J., & Rio, M. (2003) · PubMed · Cited by 88
Zijlstra, A., Seandel, M., Kupriyanova, T. A., Partridge, J. J., Madsen, M. A., Hahn-Dantona, E. A., Quigley, J. P., & Deryugina, E. I. (2005) · Blood · doi:10.1182/blood-2005-04-1458 · Cited by 86
Self-citationPericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151
Shiomi, T., Inoki, I., Kataoka, F., Ohtsuka, T., Hashimoto, G., Nemori, R., & Okada, Y. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700351 · Cited by 83
Kataoka, H., Uchino, H., Iwamura, T., Seiki, M., Nabeshima, K., & Koono, M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65292-3 · Cited by 82
Lakka, S. S., Gondi, C. S., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2003) · PubMed · Cited by 82
Hair Follicle–Derived Blood Vessels Vascularize Tumors in Skin and Are Inhibited by Doxorubicin
Amoh, Y., Li, L., Yang, M., Jiang, P., Moossa, A. R., Katsuoka, K., & Hoffman, R. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3857 · Cited by 81
Broek, I. V., Asosingh, K., Allegaert, V., Leleu, X. P., Facon, T. T. F., Vanderkerken, K., Camp, B. V., & Riet, I. V. (2004) · Leukemia · doi:10.1038/sj.leu.2403331 · Cited by 81
Björklund, M., Heikkilä, P., & Koivunen, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401601200 · Cited by 81
Stromal Cell Involvement in Cancer
Almholt, K., & Johnsen, M. (2003) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-59349-9_3 · Cited by 79
Ala‐aho, R., Ahonen, M., George, S. J., Heikkilä, J., Grenman, R. A., Kallajoki, M. A., & Kähäri, V. (2004) · Oncogene · doi:10.1038/sj.onc.1207678 · Cited by 79
Dong, Z., Nemeth, J. A., Cher, M. L., Palmer, K. C., Bright, R. C., & Fridman, R. A. (2001) · International Journal of Cancer · doi:10.1002/ijc.1358 · Cited by 77
Peek, R. M., Mohla, S., & DuBois, R. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1777 · Cited by 75
Sugino, T., Yamaguchi, T., Ogura, G., Saito, A., Hashimoto, T., Hoshi, N., Yoshida, S., Steve Goodison, B., & Suzuki, T. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-9 · Cited by 73
Local proteolytic activity in tumor cell invasion and metastasis
Ludwig, T. E. (2005) · BioEssays · doi:10.1002/bies.20306 · Cited by 71
Quest for Selectivity in Inhibition of Matrix Metalloproteinases
Brown, S., Meroueh, S. O., Fridman, R. A., & Mobashery, S. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387854 · Cited by 70
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Wyatt, C. A., Geoghegan, J. C., & Brinckerhoff, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2446 · Cited by 69
TIMP-1 Alters Susceptibility to Carcinogenesis
Rhee, J.-S., Diaz, R. J., Korets, L. V., Hodgson, J., & Coussens, L. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2445 · Cited by 66
Recent advances in the design of matrix metalloprotease inhibitors.
Matter, H., & Schudok, M. (2004) · PubMed · Cited by 65
Matrix Metalloproteinases 9 and 10 Inhibit Protein Kinase C–Potentiated, p53-Mediated Apoptosis
Meyer, É., Vollmer, J.-Y., Bovey, R., & Stamenkovic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2908 · Cited by 65
Stromelysin‐3 suppresses tumor cell apoptosis in a murine model*
Wu, E., Mari, B. P., Wang, F., Anderson, I. C., Sunday, M. E., & Shipp, M. A. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1181 · Cited by 64
Tsuji, K., Yamauchi, K., Yang, M., Jiang, P., Bouvet, M., Endo, H., Kanai, Y., Yamashita, K., Moossa, A. R., & Hoffman, R. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2958 · Cited by 63
Shiraga, M., Yano, S., Yamamoto, A., Ogawa, H., Goto, H., Miki, T., Miki, K., Zhang, H., & Sone, S. (2002) · PubMed · Cited by 61
Nishizuka, I., Ichikawa, Y., Ishikawa, T., Kamiyama, M., Hasegawa, S., Momiyama, N., Miyazaki, K., & Shimada, H. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00634-6 · Cited by 57
Chaffer, C., Dopheide, B., McCulloch, D., Lee, A. B., Moseley, J., Thompson, E., & Williams, E. (2005) · Clinical and Experimental Metastasis · doi:10.1007/s10585-005-5141-3 · Cited by 55
Cited by
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
“The most important physiological inhibitors of MMP function are the tissue inhibitors of metalloproteinases (TIMPs), which are also commonly expressed in tumor sites (Deryugina and Quigley, 2006).”
BackgroundTherapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Contribution of platelets to tumour metastasis
Gay, L. J., & Felding-Habermann, B. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3004 · Cited by 1,645
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Metadata
- Authors
- Deryugina, E. I., & Quigley, J. P.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2006-03
- Volume
- 25
- Issue
- 1
- Pages
- 9-34
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1992885568
- Cited by
- 1,960
- References
- 220
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.